Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Br J Ophthalmol. 2003 Sep;87(9):1121-5.

The association between statin use and age related maculopathy.

Author information

  • 1Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL , USA. mcgwin@eyes.uab.edu

Abstract

AIMS:

To evaluate the association between age related maculopathy (ARM) and statin use.

METHODS:

A nested case-control study among patients at the Veterans Affairs Medical Center in Birmingham, Alabama, with newly diagnosed ARM (cases) between 1997 to 2001 were selected and age matched to non-ARM controls.

RESULTS:

550 incident cases of ARM were identified and matched to 5500 controls. Overall, cases were 70% (OR 0.30, 95% CI 0.21 to 0.45) less likely to have received and filled a statin prescription relative to the controls. This association was present among both current and past (OR 0.34, 95% CI 0.21 to 0.53 and OR 0.26, 95% CI 0.14 to 0.47, respectively) statin users. When considering use of statin and/or non-statin lipid lowering medications, a significant risk reduction was observed for statin only users (OR 0.30, 95% CI 0.20 to 0.45) and combined statin and non-statin users (OR 0.20, 95% CI 0.06 to 0.64); there was no significant association for non-statin only users (OR 0.47, 95% CI 0.20 to 1.13).

CONCLUSIONS:

The results of this study suggest that subjects with ARM were significantly less likely to have filled a statin prescription. Future clinical research initiatives should include a clinical trial to provide direct evidence of the effectiveness of statins in lowering the incidence and progression of ARM.

PMID:
12928279
[PubMed - indexed for MEDLINE]
PMCID:
PMC1771871
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk